Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Heinz Feldmann and Kyle Rosenke.
Heinz Feldmann
Connection Strength
2.750
Kyle Rosenke
  1. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight. 2020 12 03; 5(23).
    View in: PubMed
    Score: 0.917
  2. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):2673-2684.
    View in: PubMed
    Score: 0.916
  3. Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nat Commun. 2021 04 16; 12(1):2295.
    View in: PubMed
    Score: 0.235
  4. Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers. J Antimicrob Chemother. 2021 01 19; 76(2):413-417.
    View in: PubMed
    Score: 0.231
  5. Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system. Antivir Ther. 2020; 25(4):223-231.
    View in: PubMed
    Score: 0.215
  6. Domestic Pig Unlikely Reservoir for MERS-CoV. Emerg Infect Dis. 2017 06; 23(6):985-988.
    View in: PubMed
    Score: 0.180
  7. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nat Commun. 2020 08 26; 11(1):4253.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.